Understanding the evolution of proliferative breast disease such as atypical hyperplasia (AH) and carcinoma in situ (CIS) is essential for clinical management of women diagnosed with these lesions. Therefore, an animal model that faithfully represents human breast disease in every aspect from spontaneousity of dysplasia onset, histopathological features, genetics, to clinical outcome is needed. Previously, we studied canine spontaneous AH and DCIS (low, intermediate and high-grade) and reported their similarities to human lesions in histopathological and molecular features as well as prevalence. To further validate the resemblance of these lesions to humans, we examined their mammographic and sonographic characteristics in comparison to those of human's as well as the potential of the human Breast Imaging Reporting and Data System (BI-RADS) to predict canine disease. Non lesional, benign and malignant mammary glands of dogs presented to Sassari Veterinary Hospital, were imaged using mammography and ultrasound. The images where then analyzed and statistically correlated with histopathological findings and to their similarities to humans. Our results showed that canine mammary preinvasive lesions, benign, and malignant tumors have mammographic abnormalities, including the presence, pattern and distribution of macro-calcification and micro-calcifications, similar to their humans' counterparts. BI-RADS categorization is an accurate predictor of mammary malignancy in canine with 90% of sensitivity and 82.8% of specificity. The mammographic images similarities and the ability of BI-RADS to predict canine mammary malignances with high specificity and sensitivity further confirm and strengthen the value of the dog as model to study human breast pre-malignancies for development of prognostic biomarkers.
Introduction
Most invasive breast cancers are thought to evolve from proliferative breast disease such as atypical hyperplasia (AH) and carcinoma in situ (CIS) lesions. These lesions are currently diagnosed more often due to increase in public awareness and routine mammographic screening (1, 2, 3) . Approximately 54,010 new cases of ductal carcinoma in situ (DCIS) are expected to be diagnosed in 2010 (4) . Despite the technological advances in detecting these lesions, their biological significance and natural history is not well understood. Five to ten percent of women diagnosed with DCIS who are treated with lumpectomy alone develop invasive cancer within five years and a similar group develops subsequent DCIS (5) . Although adjuvant treatment with radiation and tamoxifen have reduced the rates of subsequent breast cancer, these treatment regimens have not affected death rates from breast cancer (6, 7) . Studies that attempted to identify women at high risk of developing invasive cancer were not successful thus creating uncertainty in how aggressively clinicians would treat women diagnosed with DCIS (8) .
As a result, many animal models of mammary tumorigenesis, such as rodents, were developed to examine pathogenesis and progression of human breast cancer (9-10-11) . However, most mouse mammary tumors do not resemble human cancers in morphology and have different patter of metastasis, so there must be still-undetected factors that promote breast cancer development and progression in humans but are not occurring in the rodent. Therefore, rodent models may not accurately represent human breast cancer pathogenesis or reproduce many aspects of the human disease (12) (13) .
In contrast to rodents, dogs develop mammary cancer spontaneously with similar Mommographically detected DCIS is usually excised immediately and currently is not possible to estimate the fraction of untreated lesions that would progress to invasive cancer (8) . Despite the increase in detection of DCIS, the probability of definitive studies in human to demonstrate whether detection of DCIS by mammography would contribute to the reduction of breast mortality is very slim (8) . Unless these studies are conducted in animal model, that develop DCIS with similar characteristics as human. For that reason, our laboratory's focus is to characterize the dog as a model for breast cancer pre-invasive and invasive cancer.
Therefore, to complement our previous work, the purpose of this study was to determine whether the routinely used imaging techniques in human, mammography and sonography as well as interpretations of their results according to BI-RAD, could be used to detect and discriminate between preinvasive, benign and malignant mammary lesions in the dog. Our results showed that canine mammary preinvasive lesions, benign, and malignant tumors have mammographic abnormalities, including the presence, pattern, and distribution of macro-calcification and microcalcifications, similar to their humans' counterparts. BI-RADS categorization is an accurate predictor of mammary malignancy in canine with high sensitivity and specificity. The mammographic images similarities and the ability of BI-RADS to predict canine mammary malignances with high accuracy and sensitivity further confirm and strengthen the value of the dog as model to study human breast pre-malignancies. This is important for development of prognostic biomarkers to stratify women diagnosed with DCIS according to risk of developing subsequent disease.
Cancer Research. Forty-six of 88 mammary specimens that were mammography imaged were also examined by ultrasound. All ultrasound scans were performed with Esaote MyLab 70 equipped with a [15] [16] [17] [18] MHz linear multifrequency transducer. Longitudinal and transverse scans of each surgical specimen were evaluated. Ultrasound features of mammary lesions and tumor were described for mass shape (round, oval, irregular), margins (circumscribed, indistinct), echogenicity (Hyperecoic, hypoechoic, anechoic, complex mass) and also for the presence of macro-and micro-calcifications as illustrated by BI-RADS lexicon.
BI-RADS
All lesions examined by mammography and ultrasound were classified in consultation between both human and veterinary radiologists according to the American College of Radiology Breast Imaging Reporting and Data System (BI-RADS) lexicon, which provide standardized classification for mammographic and ultrasound reporting (28) . This system classifies findings into 6 assessment categories and provides 4 management outcomes. These assessment categories have been shown to correlate with the likelihood of malignancy in human breast cancer (29,30).
Depending on the level of suspicion, the lesions can be placed on the following BI-RADS categories; Category 0 when additional image evaluation is recommended, category 1 when there is no abnormality to report; category 2 for benign findings, category 3 for likely benign lesions where 6 month follow up is recommended; category 4 for suspicious abnormality and category 5 for highly suspicious lesions or diagnostic of malignancy.
Histopathological evaluation:
Cancer Research. (31) . Mammary glands were also evaluated for the presence of IELs in tumor-bearing glands and in non-tumor-bearing glands as previously described (22) (23) . Lesions were imaged using Nikon Eclipse 80i and digital computer images were recorded with a Nikon Ds-fi1 camera.
Statistical analysis
Accuracy of mammogram interpretation using the BI-RADS final assessment was determined by means of sensitivity, specificity rates, positive and negative predictive value (PPV and NPV) to differentiate between benign and malignant lesions. Histological findings were utilized as the gold standard. Statistical measures for overall lesions were calculated considering BI-RADS categories 1-2-3 as reporting of benign findings and categories 4-5 as malignant findings according to the methodology included in the BI-RADS guideline. In addition, PPV were calculated for each BI-RADS category as follows: the number of lesions in one of the categories with malignant diagnosis divided by the total number of lesions classified into this category.
All statistical calculations were performed using statistical software (Stata software, version
11.2).

Results
Mammography and ultrasound
Cancer Research. Tissues from mammary glands (88) were examined histologically and included normal (10) and tissues that carried abnormal histology (78). These lesions were classified as IELs (11) 
Discussion
We showed for the first time that mammography and ultrasound imaging as well as screening and diagnosing breast abnormalities (25) . Mammography ability to detect these abnormalities is based on the presence of microcalcifications (26) (27) . Thus this study confirms that as in humans, canine malignant mammary lesions are associated with microcalcifications, underscoring the physiological similarities between the dog and human breast disease. Until now, there has been no animal model of human breast malignancies that showed reproducible microcalcifications. Although many were developed using MMTV vectors or BRCA1/BRCA2 knockouts, however, calcification in the produced tumors is rare and unpredictable (32) (33) .
Usually suspicious microcalcifications vary in size, shape and form clusters in linear or segmental pattern that signify that the tissue may be malignant. While benign calcifications or macrocalcification tend to be large with round or oval shape and scattered in the breast (34) (35) (36) .
Thus, calcifications are considered to be one of the most important diagnostic markers of both benign and malignant lesions (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) . Correlation of mammographic features with histopathology, in this study, revealed that calcifications were present in 54% of canine mammary cases. Macrocalcifications were present in 24% while microcalcifications occurred in 29% of mammary cases. Similarly in study conducted by Sickles (38) evaluating mammographic features in human breast cancers, reported that more than half of breast cancers examined in their study had mammograpically visible calcifications. Whereas, tumor mass was the sole mammographic finding in another 26% of breast cancers. However, another 20% of cancers presented with neither mass nor calcifications (38) . In another study of 1261 occult breast abnormalities 50.4% lesions were found to have calcification and 18.8% were found to be malignant (39) .
Macrocalcification are associated with benign lesions as well as in some malignant tumors in dogs (Table 1) . Of these lesions 58% had popcorn-like shape with diffused or regional localization. Ovoid shape with regional calcifications was seen in 32% of samples. These were mostly intraepithelial lesions without atypia (11%) and benign tumors (37%). Ten lesions (52%) belong to this group (lesions with macrocalcification) were malignant but of complex type.
These tumors are of epithelial and myoepithelial origin and characterized by the presence of cartilaginous metaplasia and chondroid matrix depicted as dense calcifications by mammography (17) . Typical benign calcifications in human are similar to that we have seen in the dog, are large, smooth, popcorn-like, round, dense, and scattered over a large area. These lesions in human do not need further investigations or close follow-up (26, 34) .
About 47% of malignant tumors in this study showed microcalcification. Likewise, microcalcifications occur in about 30-50% of human breast cancers (26) . In our study, only 14% of non palpable benign lesions showed microcalcification, consistent with what observed in women where microcalcifications were seen in 14.5% of 198 and 4.5% of 1818 benign cases of asymptomatic and symptomatic women, respectively. Also microcalcifications occurred in 83% of atypical IELs in dogs. These lesions were identified histopathologically to be ADH and DCIS.
Similar to what we observed in the dog, the incidence of calcification in human DCIS ranges between 42-72% (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) . Up to 90% of DCIS lesions in human are detected based on mammograpically visible microcalcifications (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) . All canine DCIS were associated to carcinoma comedo type and contain microcalcification, and, interestingly, were mammography detected.
In addition, to the presence of microcalcifications, we examined the types and patterns of Mammographic features other than calcifications that were examined in this study included mass shape and margin. About 50% of malignant palpable and non-palpable lesions in dogs have irregular shape and indistinct margin consistent with findings found in human (38) . While majority of benign tumors were ovoid or round in shape with circumscribed margin (Table 1 Our results showed that mammography can be successfully applied to non-palpable mammary lesions in dog to detect cancer at early stages. In human medicine, mammography detects occult breast cancer with high sensitivity, which ranged from 71% -98% for annual screening mammography (46) standardize terms for reporting, the American College of Radiology has developed the Breast Imaging Reporting and Data System (BI-RADS). This system provides specific final assessment category that correlate with the likelihood of malignancy in human breast cancer. Under the Mammography Quality Standards Act (MQSA) in the United States, all screening mammograms must be interpreted using BI-RADS final assessment categories (47) (48) . Therefore, we calculated the PPV for each BI-RADS assessment category to determine if BI-RADS categorization is a good predictor of malignancy in our canine model. Based on presence or absence of masses and calcification characteristics we were able to classify our findings according to BI-RADS, which were then confirmed by pathology. The PPV for BI-RAD category 1, 2, 3, 4, and 5 are 0%, 0%, 15.79%, 71.43% and 100% respectively ( Table 2 ).
According to BI-RADS category in our study the sensitivity and the specificity of diagnostic mammography was of 90% and 83%, making this system an excellent predictor of mammary malignancy in palpable and non-palpable mammary canine disease. This is the first time that BI-RADS are applied to other species than humans. This study has demonstrated that the dog mammary neoplasm form micro and macrocalcification similar to humans. The study also suggests that the process of cancer pathogenesis may be similar in the two species. Furthermore, mammography and sonography features of canine mammary IELs, benign and invasive cancer correlate with the histopathological findings and the BI-RADS classification is a good predictor of malignancies in the dog. This further provides more evidences to the value of the dogs as model for breast cancer. The research might allow examination of breast pre-malignancies for development of prognostic biomarkers.
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